Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02434653
Other study ID # 0112-14
Secondary ID
Status Completed
Phase N/A
First received April 28, 2015
Last updated July 12, 2017
Start date June 2015
Est. completion date May 2017

Study information

Verified date May 2017
Source HaEmek Medical Center, Israel
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Anemia diagnosis by hemoglobin level monitoring in women after vaginal delivery by symptoms versus screening of women at increased risk for post-partum anemia.


Description:

Anemia is common following delivery. It is associated with some serious complications including increased risk for syncope and in severe cases even cardiogenic shock. Yet, anemia-associated symptoms might manifest relatively late after the patient have lost a fair amount of blood, which was not diagnosed early enough. To date, there are not acceptable guidelines for monitoring hemoglobin levels after delivery. Theoretically, there are 2 approaches for hemoglobin monitoring - one by taking hemoglobin levels in order to diagnose anemia in patients reporting anemia-associated symptoms. The other approach is by screening of women at increased risk for post-partum anemia. In the present study we aimed to compare those 2 approaches.


Recruitment information / eligibility

Status Completed
Enrollment 1679
Est. completion date May 2017
Est. primary completion date May 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- pregnant women after vaginal delivery

Exclusion Criteria:

- pregnant women with known sensitivity to the product iron sucrose

- pregnant women after cesarean section

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Monitoring hemoglobin levels following anemia associated symptoms
Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to patients with symptoms consistent with anemia, severe postpartum hemorrhage or hemoglobin level below 8 g/dL.
Monitoring hemoglobin levels to detect anemia by screening of women at increased risk for post partum anemia
Post-partum anemia will be diagnosed after vaginal delivery by taking hemoglobin levels to high risk women for post-partum anemia, defined as hemoglobin levels of 10.5 g/dl or below around delivery, or severe postpartum hemorrhage with or without symptoms associated with anemia

Locations

Country Name City State
Israel Haemek Medical Center Afula

Sponsors (1)

Lead Sponsor Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary The rate of patients diagnosed with anemia Hemoglobin of 10 g/dl or below Up to 3 days postpartum
Primary The rate of patients who received treatment with intravenous iron sucrose Up to 3 days postpartum
Secondary The rate of patients who received blood transfusion From delivery and up to 5 days
Secondary The rate of women with post-partum hemorrhage From delivery and up to 5 days
Secondary The rate of women who underwent uterine revision following delivery after their arrival to the maternity ward From delivery and up to 5 days
Secondary The rate of women who needed uterotonic agents after their arrival to the maternity ward From delivery and up to 5 days
Secondary The average blood tests number that was performed From delivery and up to 5 days
Secondary Minimal and average hemoglobin level From delivery and up to 5 days
Secondary The composite symptoms of anemia and functional capacity after 6 weeks postpartum as assessed by a questionnaire Each question in the questionnaire will receive a score. The total score will be reported. 6 weeks postpartum
Secondary Hemoglobin level 6 weeks postpartum 6 weeks postpartum
See also
  Status Clinical Trial Phase
Recruiting NCT05590260 - Prevention of Iron Deficiency Anemia Post-delivery Phase 3
Completed NCT01628770 - Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia N/A
Completed NCT00354484 - Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients Phase 3
Recruiting NCT02656225 - Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome Phase 1/Phase 2
Not yet recruiting NCT06175117 - Clinical Study on the Treatment of Postpartum Anemia With Compound E Jiao Jiang(cEJJ) Phase 4
Completed NCT02458625 - A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia N/A